Resmetirom
CAS: 920509-32-6
Ref. 3D-VLB50932
| 10mg | 189.00 € | ||
| 25mg | 273.00 € | ||
| 50mg | 400.00 € | ||
| 100mg | 569.00 € | ||
| 250mg | 814.00 € |
Product Information
Resmetirom, also known as MGL-3196, is a promising drug for the treatment of hyperlipidemia and nonalcoholic steatohepatitis (NASH)(now known as metabolic dysfunction-associated steatohepatitis (MASH). It is an orally active, liver-directed, selective thyroid hormone receptor-beta agonist. Resmetirom works by targeting the thyroid hormone receptor-beta to regulate hepatic triglyceride and cholesterol metabolism, thereby reducing hepatic fat content. In clinical trials, resmetirom has shown significant reductions in liver fat content in patients with NASH without major side effects. Additionally, resmetirom has been found to improve atherogenic dyslipidemia associated with NASH by positively impacting triglyceride and LDL cholesterol levels.
Chemical properties
Technical inquiry about: 3D-VLB50932 Resmetirom
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
